Skip to Main Content

Author Details

Xuhong Cao
Michigan Center for Translational Pathology.
1999
138
66
PMIDPaper TitleJournal TitlePublished Year
37994665Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.Am J Surg Pathol2024
36264673Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlates.Cancer Cytopathol2023
37714137Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA.Cell2023
38011559Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy.Proc Natl Acad Sci U S A2023
35605606Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.Neuro Oncol2023
37459541Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.Proc Natl Acad Sci U S A2023
37267699Genomics driven precision oncology in advanced biliary tract cancer improves survival.Neoplasia2023
37094128Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas.Proc Natl Acad Sci U S A2023
36581128Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma.Hum Pathol2023
36828361Highly Recurrent IDH1 Mutations in Prostate Cancer With Psammomatous Calcification.Mod Pathol2023
36250542Characterization of Intercalated Cell Markers KIT and <i>LINC01187</i> in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms.Int J Surg Pathol2023
34474081Viral Status Predicts the Patterns of Genome Methylation and Decitabine Response in Merkel Cell Carcinoma.J Invest Dermatol2022
35513774Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer.BMC Cancer2022
36511267Deciphering intratumor heterogeneity in clear cell renal cell carcinoma utilizing clinicopathologic and molecular platforms.Hum Pathol2022
35923912Argonaute 2 modulates EGFR-RAS signaling to promote mutant <i>HRAS</i> and <i>NRAS-</i>driven malignancies.PNAS Nexus2022
34937944Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.Nature2022
34904395Chicken ISG12(2) attenuates Newcastle disease virus and enhances the efficiency of Newcastle disease vaccine via activating immune pathways.Transbound Emerg Dis2022
33398162Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination.Nat Med2021
35602214Characterization of SARS-CoV-2 and host entry factors distribution in a COVID-19 autopsy series.Commun Med (Lond)2021
33854184TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma.Mod Pathol2021
33630025Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.JAMA Oncol2021
33753452Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer.Clin Cancer Res2021
34738088Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer.Nat Cancer2021
34099557Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response.Proc Natl Acad Sci U S A2021
34062443Musashi1 inhibit the release of Newcastle disease viruses through preventing apoptosis of DF-1 cells.Poult Sci2021
33972443AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer.Proc Natl Acad Sci U S A2021
33310900Targeting transcriptional regulation of SARS-CoV-2 entry factors <i>ACE2</i> and <i>TMPRSS2</i>.Proc Natl Acad Sci U S A2021
32299640Next-generation RNA Sequencing-based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.Eur Urol2020
31931431Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment.Neoplasia2020
33168847Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors.Sci Rep2020
32616231Screening and mechanistic study of key sites of the hemagglutinin-neuraminidase protein related to the virulence of Newcastle disease virus.Poult Sci2020
32499547An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development.Nat Commun2020
30797188Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma.Neoplasia2019
31638990Plasmacytoid urothelial carcinoma: a rapid autopsy case report with unique clinicopathologic and genomic profile.Diagn Pathol2019
31243372Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.Nature2019
30712214Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements-a clinicopathologic and genomic sequencing-based discussion.Med Oncol2019
30735636The Landscape of Circular RNA in Cancer.Cell2019
30918020Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration-resistant Prostate Cancer.Clin Cancer Res2019
28840857Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.Mod Pathol2018
32832832Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors.JCO Precis Oncol2018
30135193Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer.Cancer Res2018
29808028Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression.Nat Genet2018
29941307Somatic Bi-allelic Loss of TSC Genes in Eosinophilic Solid and Cystic Renal Cell Carcinoma.Eur Urol2018
29906450Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.Cell2018
29899824Clinical validation of the Tempus xO assay.Oncotarget2018
29976978Genetic diversity of NDUFV1-dependent mitochondrial complex I deficiency.Eur J Hum Genet2018
30268942MiPanda: A Resource for Analyzing and Visualizing Next-Generation Sequencing Transcriptomics Data.Neoplasia2018
30291535Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.Med Oncol2018
30285995VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.Am J Surg Pathol2018
29261439Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.J Clin Oncol2018
  • 1 - 50 of 138

Recommended Authors

Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 2
Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 23
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 22
Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 5
Daniel H Hovelson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2014
Number of shared co-authors 34
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 44
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 16
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 18
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 21
Kyung Park
New York University Langone Health
Career Start Year 2010
Number of shared co-authors 36
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 9
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 29
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 17
David A Quigley
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 22
Alexander W Wyatt
University of British Columbia
Career Start Year 2007
Number of shared co-authors 36
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 12
Barry S Taylor
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 43
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 14
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 39
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 7
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 4
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 6
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 8
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 3
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 24
Anna Lapuk
Contextual Genomics Inc.
Career Start Year 1998
Number of shared co-authors 11
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 18
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 17
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 2
Matthew Meyerson
Broad Institute
Career Start Year 1983
Number of shared co-authors 39

Collaborators

Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 132
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 63
Saravana M Dhanasekaran
Co-authored papers 48
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 39
Yi-Mi Wu
University of Michigan Medical School ann arbor
Co-authored papers 39
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 37
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 35
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 32
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 25
Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 23
Nallasivam Palanisamy
Vattikuti Urology Institute
Co-authored papers 23
Marcin Cieslik
Co-authored papers 23
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Co-authored papers 22
John R Prensner
University of Michigan ann arbor
Co-authored papers 21
Chandan Kumar-Sinha
Co-authored papers 20
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 19
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 19
Mark A Rubin
University of Bern
Co-authored papers 14
Christopher A Maher
Washington University in St Louis
Co-authored papers 11
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 9
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 8
David C Smith
Rogel Comprehensive Cancer Center, University of Michigan ann arbor
Co-authored papers 8
Moshe Talpaz
University of Michigan Rogel Cancer Center.
Co-authored papers 7
Zhaohui S Qin
Emory University
Co-authored papers 7
Jianjun Yu
Co-authored papers 7
Thomas J Giordano
University of Michigan ann arbor
Co-authored papers 6
Rajen Mody
Co-authored papers 6
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Ram S Mani
UT Southwestern Medical Center
Co-authored papers 6
Nora M Navone
MD Anderson Cancer Center
Co-authored papers 6
Release 1.2